1. NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence. JAMA. 1993. 270:83–90.
2. Melman A, Gingell JC. The epidemiology and pathophysiology of erectile dysfunction. J Urol. 1999. 161:5–11.
3. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol. 1994. 151:54–61.
4. Althof SE, Corty EW, Levine SB, Levine F, Burnett AL, McVary K, et al. EDITS: development of questionnaires for evaluating satisfaction with treatments for erectile dysfunction. Urology. 1999. 53:793–799.
5. Tellaloğlu S, Kadioğlu A. Sexual dysfunction in men, In Series of Andrology. 2000. Istanbul: Nobel Medical Co;143–147.
6. McClure RD, Marshall G. Singer C, Weiner WJ, editors. Endocrinologic sexual dysfunction. Sexual Dysfunction: A Neuro-Medical Approach. 1994. Armonk, NY: Futura Publishing Co;245–273.
7. Govier FE, McClure RD, Kramer-Levien D. Endocrine screening for sexual dysfunction using free testosterone determinations. J Urol. 1996. 156:405–408.
8. McClure RD. Endocrine evaluation and therapy of erectile dysfunction. Urol Clin North Am. 1988. 15:53–64.
9. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The International Index of Erectile Function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology. 1997. 49:822–830.
10. Cappelleri JC, Siegel RL, Glasser DB, Osterloh IH, Rosen RC. Relationship between patient self-assessment of erectile dysfunction and the sexual health inventory for men. Clin Ther. 2001. 23:1707–1719.
11. de la Torre B, Sjöberg B, Hedman M, Bártfai G, Diczfalusy E. A study of the short-time variation and interrelationship of plasma hormone levels reflecting pituitary, adrenocortical and testicular function in fertile men. Int J Androl. 1981. 4:532–545.
12. Gray A, Feldman HA, McKinlay JB, Longcope C. Age, disease and changing sex hormone levels in middle-aged men: results of the Massachusetts Male Aging Study. J Clin Endocrinol Metab. 1991. 73:1016–1025.
13. Ansong KS, Punwaney RB. An assessment of the clinical relevance of serum testosterone level determination in the evaluation of men with low sexual drive. J Urol. 1999. 162(3 Pt 1):719–721.
14. Davidson JM, Camargo CA, Smith ER. Effects of androgen on sexual behavior in hypogonadal men. J Clin Endocrinol Metab. 1979. 48:955–958.
15. Deslypere JP, Vermeulen A. Leydig cell function in normal men: effect of age, life-style, residence, diet, and activity. J Clin Endocrinol Metab. 1984. 59:955–962.
16. Vekemans M, Robyn C. Influence of age on serum prolactin levels in women and men. Br Med J. 1975. 27:738–739.
17. Korenman SG, Morely JF, Mooradian AG, Davis SS, Kaiser FE, Silver AJ, et al. Secondary hypogonadism in older men: its relation to impotence. J Clin Endocrinol Metab. 1990. 71:963–969.
18. Fahmy AK, Mitra S, Blacklock AR, Desai KM. Is the measurement of serum testosterone routinely indicated in men with erectile dysfunction? BJU Int. 1999. 84:482–484.
19. Kaiser FE, Viosca SP, Morley JE, Mooradian AD, Davis SS, Korenman SG. Impotence and aging: clinical and hormonal factors. J Am Geriatr Soc. 1988. 36:511–519.
20. Johnson AR 3rd, Jarow JP. Is routine endocrine testing of impotent men necessary? J Urol. 1992. 147:1542–1544.
21. Slag MF, Morley JE, Elson MK, Trence DL, Nelson CJ, Nelson AE, et al. Impotence in medical clinic outpatients. JAMA. 1983. 249:1736–1740.
22. Buvat J, Lemaire A. Endocrine screening in 1022 men with erectile dysfunction: clinical significance and cost-effective strategy. J Urol. 1997. 158:1764–1767.
23. Baskin HJ. Endocrinologic evaluation of impotence. South Med J. 1989. 82:446–449.
24. Foster RS, Mulcahy JJ, Callaghan JT, Crabtree R, Brashear D. Role of serum prolactin determination in evaluation of impotent patient. Urology. 1990. 36:499–501.
25. Zonszein J. Diagnosis and management of endocrine disorders of erectile dysfunction. Urol Clin North Am. 1995. 22:789–802.